Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

Clinical trial NCT05181046 · COMPLETED

Trial details

NCT number: NCT05181046
Sponsor: Nanodropper, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glaucoma Glaucoma, Open-Angle Glaucoma, Primary Open Angle Glaucoma and Ocular Hypertension Ocular Hypertension

Start date: 2021-11-06
Primary completion: 2022-12-19
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.